Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Medical Genetics|June 2, 2012
Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasmsEduard Schulz, Angelika Valentin, Peter Ulz, et al.
Bone Marrow Transplantation|July 20, 2023
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host diseaseDavid Beshensky, Filip Pirsl, Noa G Holtzman, et al.
Bone Marrow Transplantation|September 8, 2023
Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host diseaseAaron T Zhao, Filip Pirsl, Seth M Steinberg, et al.
Critical Care Explorations|March 21, 2024
Ruxolitinib, IV Immunoglobulin, and High-Dose Glucocorticoids for Critically Ill Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-Center Observational Pilot StudyLaura Scholz, Florian Posch, Eduard Schulz, et al.
Therapeutic Advances in Hematology|January 6, 2022
Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort studyWalter Spindelboeck, Bettina Halwachs, Nadine Bayer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 24, 2021
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathyStefan Hatzl, Florian Posch, Arwin Rezai, et al.
Frontiers in Immunology|December 24, 2021
CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised PatientsEduard Schulz, Isabel Hodl, Patrick Forstner, et al.
Microbes and Infection|January 21, 2023
Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapyIsabel Hodl, Clarissa Sallegger, Patrick Forstner, et al.
Blood|May 7, 2025
Phase 1/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCTEduard Schulz, Lauren M Curtis, Noa G Holtzman, et al.
Vaccine|August 29, 2025
Altered immune responses to mRNA vaccination against SARS-COV-2 are characterized by an impaired cross-talk between humoral and T-cellular immune compartments in patients with hematologic diseasesStefan Hatzl, Florian Posch, Eduard Schulz, et al.
Pageof 3